Refractory Malignant Solid Neoplasm Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Recurrent Alveolar Rhabdomyosarcoma
  • +7 more
  • Birmingham, Alabama
  • +17 more
2022-04-07
Apr 7, 2022
N
Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +108 more
2022-04-06
Apr 6, 2022
N
Active, not recruiting
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
2022-04-05
Apr 5, 2022
N
Recruiting
  • Malignant Solid Neoplasm
  • +2 more
  • Birmingham, Alabama
  • +11 more
2022-04-02
Apr 2, 2022
N
Recruiting
  • Metastatic Colorectal Carcinoma
  • +29 more
  • Los Angeles, California
  • +22 more
2022-03-29
Mar 29, 2022
N
Not yet recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • (no location specified)
2022-03-30
Mar 30, 2022
M
Active, not recruiting
  • Recurrent Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-24
Mar 24, 2022
N
Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +22 more
  • Birmingham, Alabama
  • +116 more
2022-03-23
Mar 23, 2022
C
Recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +10 more
  • FACT Complex-targeting Curaxin CBL0137
  • Birmingham, Alabama
  • +13 more
2022-03-22
Mar 22, 2022
C
Active, not recruiting
  • Recurrent Lymphoma
  • +5 more
  • Birmingham, Alabama
  • +19 more
2022-03-23
Mar 23, 2022
N
Active, not recruiting
  • Metastatic Melanoma
  • +3 more
  • Jacksonville, Florida
  • +1 more
2022-03-15
Mar 15, 2022
N
Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Duarte, California
  • +8 more
2022-03-15
Mar 15, 2022
N
N
Suspended
  • Advanced Malignant Solid Neoplasm
  • +32 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +121 more
2022-03-08
Mar 8, 2022